CEVEC PHARMACEUTICALS
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
CEVEC PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
2003-01-01
Address:
Köln, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.cevec.com
Total Employee:
11+
Status:
Active
Contact:
+49022146020800
Email Addresses:
[email protected]
Total Funding:
24.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache Wordpress Plugins Pound Sterling Google Search Appliance
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Current Employees Featured
Investors List
NRW.BANK
NRW.BANK investment in Venture Round - CEVEC Pharmaceuticals
NRW.BANK
NRW.BANK investment in Venture Round - CEVEC Pharmaceuticals
Creathor Ventures
Creathor Ventures investment in Venture Round - CEVEC Pharmaceuticals
Peppermint Venture Partners
Peppermint Venture Partners investment in Venture Round - CEVEC Pharmaceuticals
NRW.BANK
NRW.BANK investment in Venture Round - CEVEC Pharmaceuticals
ERP Startfonds
ERP Startfonds investment in Venture Round - CEVEC Pharmaceuticals
Creathor Ventures
Creathor Ventures investment in Venture Round - CEVEC Pharmaceuticals
NRW.BANK
NRW.BANK investment in Series B - CEVEC Pharmaceuticals
Creathor Ventures
Creathor Ventures investment in Series B - CEVEC Pharmaceuticals
ERP Startfonds
ERP Startfonds investment in Series B - CEVEC Pharmaceuticals
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Official Site Inspections
http://www.cevec.com Semrush global rank: 4.96 M Semrush visits lastest month: 1.71 K
- Host name: 172.67.183.13
- IP address: 172.67.183.13
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CEVEC Pharmaceuticals"
CEVEC Pharmaceuticals - Crunchbase Company Profile …
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production …See details»
Cytiva strengthens cell line development with CEVEC acquisition
Oct 6, 2022 Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing …See details»
CEVEC Pharmaceuticals Opens US Subsidiary - bionity.com
Nov 17, 2010 CEVEC Pharmaceuticals announced the US expansion of it’s business by founding a North American subsidiary, CEVEC Pharmaceuticals, Inc., in Potomac, Maryland, …See details»
CEVEC Pharmaceuticals CEO and Key Executive Team - Craft
CEVEC Pharmaceuticals's Chief Executive Officer is Nicole Faust. Other executives include Ulrich Kettling, Chief Business Officer; Klaus Zimmermann, Board Member and 5 others. See …See details»
Patents Assigned to Cevec Pharmaceuticals GmbH
Aug 1, 2018 Abstract: The present invention relates to methods for the selection of a stable producer cell line expressing one or more protein (s) of interest (POIs), comprising the stable …See details»
CEVEC Pharmaceuticals - VentureRadar
"CEVEC Pharmaceuticals is a leading provider of high-performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale. The company’s …See details»
Nicole Faust (Cevec Pharmaceuticals GmbH) - life-sciences …
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the successful closing …See details»
Cevec (Group) - life-sciences-europe.com
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP®GT is a fully scalable manufacturing platform for viral …See details»
CEVEC Pharmaceuticals GmbH - Mergers and Acquisitions (MandA ...
MarketLines CEVEC Pharmaceuticals GmbH Mergers and Acquisitions (MandA), Partnerships and Alliances and Investments report includes business description, detailed reports on …See details»
Elevecta® technology (for AAV vectors production) Cevec …
CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale. The company’s product portfolio …See details»
Cytiva strengthens cell line development with CEVEC acquisition
Oct 6, 2022 /PRNewswire/ -- Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and...See details»
Roche in Agreement to Use CEVEC’s ELEVECTA Technology for …
Nov 23, 2020 The agreement will allow Roche to use CEVEC’s proprietary ELEVECTA technology, which is designed to enable fully scalable, high-performance AAV vector …See details»
CEVEC Pharma Raises $8.5 Million to Commercialize ... - Fierce …
Jul 28, 2011 CEVEC Pharma Raises $8.5 Million to Commercialize Human-Cell Expression Platform for Proteins and Vaccines 7/25/2011 8:16:57 AM Cologne, Germany, July 25, 2011 / …See details»
Cevec - The Index Project
Cevec is a product system that enables paramedics to administer medication by inserting a central venous catheter quickly and safely. It considers the specific conditions of emergency …See details»
CEVEC and UCB Sign Agreement for the use of CEVEC's …
Sep 7, 2021 According to the agreement, CEVEC grants UCB non-exclusive rights for research and development using ELEVECTA(R) producer cell lines for specific transgenes selected by …See details»
Cevec Pharmaceuticals GmbH. (10/19/20). "Press Release: Cevec …
CEVEC Pharmaceuticals GmbH (CEVEC) and Rznomics Inc. (Rznomics) today announced the signing of a clinical and commercial license agreement for the use of CEVEC’s proprietary …See details»
Articles about CEVEC - BioSpace
Based on its proprietary CAP-GT manufacturing platform of suspension cell lines, CEVEC has successfully developed a novel AAV stable production system that allows for easy scale up in …See details»
Scalable production of gene therapy vectors: an interview with …
Oct 26, 2015 CEVEC’s CAP®GT expression platform is a fully scalable production system for gene therapy vectors with broad regulatory endorsement.See details»
Reduction of encapsidated hcDNA during AAV production
Feb 7, 2024 Helmut Kewes is a scientist in the Technology Development department at Cevec—now part of Cytiva—with more than 15 years of experience in cell line development, …See details»
CEVEC signs agreement with Roche for gene therapy technology
Nov 11, 2020 CEVEC Pharmaceuticals has signed an option and license agreement with Roche for the use of its newly launched ELEVECTA Technology for large scale manufacturing of …See details»